A Cross-Sectional Study on the Impact of Operation Triple Zero (OTZ) Program on Viral Load Suppression amongst Members of the Adolescent Club in 68 Nigerian Army Reference Hospital Yaba Lagos, Nigeria
Background: In Nigeria, adolescents and young people (AYP) aged 10 - 24, comprise 22.3% of the population and with HIV prevalence of 3.5%. The AYP living with HIV enrolled at the 68 NARHY, Lagos reflects the national challenges with poor viral suppression. The OTZ program aligns with the UNAIDS 95-95-95 goals. It seeks to empower AYPLHIV to be in charge of their treatment and commit to triple zero outcomes—zero missed appointments, zero missed drugs, and zero viral loads. The purpose of the study was to assess the impact of the OTZ program on viral load suppression among members of the adolescent club in 68 NARHY, Lagos. Method: A cross-sectional retrospective study to evaluate the impact of the OTZ program on the viral load of 53 AYP enrolled in the OTZ program between March 2019 to December 2019 was analyzed. The Percentage of viral load suppression before enrollment compared with 6 and 12 months after enrollment into the OTZ program. The AYP is grouped into 10 - 14, 15 - 19, and 20 - 24 years. Activities conducted were peer driven monthly meetings with the AYP during which the adolescents interacted on issues relating to improving their treatment outcomes, healthcare workers reviewed their clinical status, viral load result, provider peer counseling, and caregivers’ engagement to support adherence to medication and ARV refills. Results: Before OTZ, 81% aged 10 - 14 years, 75% aged 15 - 19 years, and 25% aged 20 - 24 years were virally suppressed (VL less than 1000 copies/ml). Six months after enrollment, 94% were virally suppressed—95% aged 10 - 14 years, 96% aged 15 - 19 years, and 66% aged 20-24 years. Twelve months after enrollment, 96% of AYP were virally suppressed—100% aged 10-14 years, 93% aged 15 - 19 years, and 100% aged 20 - 24 years. Males’ viral load (VL) suppression improved from 79% to 96% and 92%, while females’ VL suppression improved from 69% to 93% and 100% at 6 and 12 months respectively. Conclusion: The OTZ activities contributed to improved viral load suppression in the AYP of the facility.
References
[1]
Joint United Nations Programme on HIV/AIDS (UNAIDS) (2019) New Survey Results Indicate That Nigeria Has an HIV Prevalence of 1.4%. https://www.unaids.org/sites/default/files/20190314_PR_Nigeria_en.pdf
[2]
Joint United Nations Programme on HIV/AIDS (UNAIDS) (2014) The Gap Report. https://www.unaids.org/en/resources/documents/2014/20140716_UNAIDS_gap_report
[3]
National Agency for the Control of AIDS (NACA) (2016) National HIV Strategy for Adolescents and Young People 2016-2020. https://naca.gov.ng/national-hiv-strategy-for-adolescents-and-young-people/
[4]
Johnston, R. (2016) Arsenic and the 2030 Agenda for Sustainable Development. Arsenic Research and Global Sustainability—Proceedings of the 6th International Congress on Arsenic in the Environment, New York, 25-27 September 2015, 12-14. https://doi.org/10.1201/B20466-7
[5]
Oryokot, B., Miya, Y., Logose, B., Ajambo, E., Oluka, A.I., Odoi, C., Etukoit, B.M., Mugenyi, L. and Mugisha, K. (2020) Interventions to Improve HIV Viral Load Suppression among the Adolescents: Evidence of Improvement Science through a Quality Improvement Approach in Eastern Uganda. World Journal of Aids, 10, 94-106. https://doi.org/10.4236/wja.2020.102008
[6]
Inzaule, S.C., Hamers, R.L., Kityo, C., Rinke de Wit, T.F. and Roura, M. (2016) Long-Term Antiretroviral Treatment Adherence in HIV-Infected Adolescents and Adults in Uganda: A Qualitative Study. PLOS ONE, 11, e0167492. https://doi.org/10.1371/journal.pone.0167492
[7]
Nabukeera-Barungi, N., Elyanu, P., Asire, B., Katureebe, C., Lukabwe, I., Namusoke, E., Musinguzi, J., Atuyambe, L. and Tumwesigye, N. (2015) Adherence to Antiretroviral Therapy and Retention in Care for Adolescents Living with HIV from 10 Districts in Uganda. BMC Infectious Diseases, 15, Article No. 520. https://doi.org/10.1186/s12879-015-1265-5
[8]
Chhim, K., Mburu, G., Tuot, S., Sopha, R., Khol, V., Chhoun, P. and Yi, S. (2018) Factors Associated with Viral Non-Suppression among Adolescents Living with HIV in Cambodia: A Cross-Sectional Study. AIDS Research and Therapy, 15, Article No. 20. https://doi.org/10.1186/s12981-018-0205-z
[9]
Jobanputra, K., Parker, L.A., Azih, C., Okello, V., Maphalala, G., Kershberger, B., Khogali, M., Lujan, J., Antierens, A., Teck, R., Ellman, T., Kosgei, R. and Reid, T. (2015) Factors Associated with Virological Failure and Suppression after Enhanced Adherence Counselling in Children, Adolescents and Adults on Antiretroviral Therapy for HIV in Swaziland. PLOS ONE, 10, e0116144. https://doi.org/10.1371/journal.pone.0116144
[10]
Isaac, E., Ajani, A., Iliya, J., Christianah, O. and Hassan, D. (2020) HIV Viral Suppression in Children in a Subnational Antiretroviral Treatment Programme in Nigeria. World Journal of AIDS, 10, 170-185.
[11]
World Health Organization (2019) Technical Brief: Adolescent-Friendly Health Services for Adolescent Living with HIV: From Theory to Practice. p. 7. https://www.who.int/publications/i/item/adolescent-friendly-health-services-for-adolescents-living-with-hiv
[12]
PEPFAR Solutions Platform (2018) Operation Triple Zero: Empowering Adolescents and Young People Living with HIV to Take Control of Their Health in Kenya. https://www.pepfarsolutions.org/solutions/2018/10/30/operation-triple-zero-empowering-adolescents-and-young-people-living-with-hiv-to-take-control-of-their-own-health
[13]
Joint United Nations Programme on HIV/AIDS (UNAIDS) (2014) Fast-Track Ending the Aids Epidemic by 2030. https://www.unaids.org/sites/default/files/media_asset/JC2686_WAD2014report_en.pdf
[14]
Mwangi, A. and van Wyk, B. (2021) Factors Associated with Viral Suppression among Adolescents on Antiretroviral Therapy in Homa Bay County, Kenya: A Retrospective Cross-Sectional Study. HIV/AIDS (Auckland, N.Z.), 13, 1111-1118. https://doi.org/10.2147/HIV.S345731
[15]
Okonji, E.F., van Wyk, B., Mukumbang, F.C. and Hughes, G.D. (2021) Determinants of Viral Suppression among Adolescents on Antiretroviral Treatment in Ehlanzeni District, South Africa: A Cross-Sectional Analysis. AIDS Research and Therapy, 18, Article No. 66. https://doi.org/10.1186/s12981-021-00391-7
[16]
UN Women (2018) Facts and Figures: HIV and AIDS. https://www.unwomen.org/en/what-we-do/hiv-and-aids/facts-and-figures
[17]
Joint United Nations Programme on HIV/AIDS (UNAIDS) (2022) UNAIDS Global AIDS Update. https://www.unaids.org/sites/default/files/media_asset/2022-global-aids-update-summary_en.pdf
[18]
Center for International Health, Education and Biosecurity (2021) Operation Triple Zero Supports Adolescents in Overcoming HIV. https://www.ciheb.org/News/Impact-Stories/2021-Impact-Stories/Operation-Triple-Zero-Supports-Adolescents-in-Overcoming-HIV.html
[19]
Van Wyk, B.E., Kriel, E. and Mukumbang, F. (2020) Two-Year Viral Load Suppression among Adolescents Receiving Antiretroviral Therapy in the Cape Metropole, South Africa, 2013-2015: A Retrospective Cohort Analysis. South African Medical Journal, 110, 1213-1217. https://doi.org/10.7196/SAMJ.2020.v110i12.14509
[20]
Umar, E., Levy, J.A., Bailey, R.C., Donenberg, G., Hershow, R.C. and Mackesy-Amiti, M.E. (2019) Virological Non-Suppression and Its Correlates among Adolescents and Young People Living with HIV in Southern Malawi. Aids and Behavior, 23, 513-522. https://doi.org/10.1007/s10461-018-2255-6
[21]
Muri, L., Gamell, A., Ntamatungiro, A.J., Glass, T.R., Luwanda, L.B., Battegay, M., Furrer, H., Hatz, C., Tanner, M., Felger, I., Klimkait, T., Letang, E. and KIULARCO Study Group (2017) Development of HIV Drug Resistance and Therapeutic Failure in Children and Adolescents in Rural Tanzania: An Emerging Public Health Concern. AIDS (London, England), 31, 61-70. https://doi.org/10.1097/QAD.0000000000001273
[22]
Bulage, L., Ssewanyana, I., Nankabirwa, V., Nsubuga, F., Kihembo, C., Pande, G., Ario, A.R., Matovu, J.K., Wanyenze, R.K. and Kiyaga, C. (2017) Factors Associated with Virological Non-Suppression among HIV-Positive Patients on Antiretroviral Therapy in Uganda, August 2014-July 2015. BMC Infectious Diseases, 17, Article No. 326. https://doi.org/10.1186/s12879-017-2428-3
[23]
Kipp, W., Alibhai, A., Saunders, L.D., Senthilselvan, A., Kaler, A., Konde-Lule, J., Okech-Ojony, J. and Rubaale, T. (2010) Gender Differences in Antiretroviral Treatment Outcomes of HIV Patients in Rural Uganda. AIDS Care, 22, 271-278. https://doi.org/10.1080/09540120903193625
[24]
Colvin, C.J. (2019) Strategies for Engaging Men in HIV Services. The Lancet HIV,6, e191-e200. https://doi.org/10.1016/S2352-3018(19)30032-3
